Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Savant Capital LLC

Savant Capital LLC reduced its position in Bath & Body Works, Inc. (NYSE:BBWI) by 16.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,810 shares of the company’s stock after selling 1,516 shares during the quarter. Savant Capital LLC’s holdings in Bath & Body Works were worth $337,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Bath & Body Works by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after purchasing an additional 67,920 shares in the last quarter. Darsana Capital Partners LP acquired a new position in shares of Bath & Body Works during the third quarter worth about $76,050,000. Charles Schwab Investment Management Inc. increased its stake in shares of Bath & Body Works by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,925,647 shares of the company’s stock worth $65,087,000 after buying an additional 27,627 shares during the period. Alua Capital Management LP raised its holdings in Bath & Body Works by 30.2% in the third quarter. Alua Capital Management LP now owns 1,693,200 shares of the company’s stock valued at $57,230,000 after acquiring an additional 392,800 shares in the last quarter. Finally, Earnest Partners LLC lifted its stake in Bath & Body Works by 1,055,015.7% in the third quarter. Earnest Partners LLC now owns 1,276,690 shares of the company’s stock worth $43,152,000 after acquiring an additional 1,276,569 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the sale, the insider now owns 45,992 shares in the company, valued at $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.19% of the company’s stock.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $47.38 on Tuesday. The firm’s fifty day simple moving average is $46.07 and its 200-day simple moving average is $41.15. Bath & Body Works, Inc. has a 12 month low of $27.30 and a 12 month high of $50.34. The stock has a market capitalization of $10.66 billion, a price-to-earnings ratio of 12.31, a PEG ratio of 1.49 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.84 billion. During the same period in the prior year, the company earned $1.86 earnings per share. The business’s revenue was up .8% compared to the same quarter last year. Analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 1.69%. Bath & Body Works’s payout ratio is 20.78%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on BBWI. The Goldman Sachs Group raised their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a report on Monday, March 4th. Wells Fargo & Company raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 24th. UBS Group upped their price objective on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. Robert W. Baird raised their target price on Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $53.00 price target on shares of Bath & Body Works in a report on Friday, April 5th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $46.73.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.